Tarsus Pharmaceuticals, Inc.
TARS· Nasdaq
Released May 11, 2021, after the close
10-Q filed May 11, 2021, 41 days after period end · 0001819790-21-000020
| Metric | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|
| Revenue | $33.43M | $0.00 | — |
| Net Income | $10.38M | -$1.96M | -$1.75M |
| EPS Diluted | $0.47 | -$0.74 | — |
Tarsus Pharmaceuticals, Inc. · CIK 1819790 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.